Form 8-K - Current report:
SEC Accession No. 0001493152-24-047145
Filing Date
2024-11-21
Accepted
2024-11-21 16:15:23
Documents
13
Period of Report
2024-11-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38726
  Complete submission text file 0001493152-24-047145.txt   216093

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE telo-20241118.xsd EX-101.SCH 3030
3 XBRL LABEL FILE telo-20241118_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE telo-20241118_pre.xml EX-101.PRE 24175
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3895
Mailing Address 100 SE 2ND ST SUITE 2000 #1009 MIAMI FL 33131
Business Address 100 SE 2ND ST SUITE 2000 #1009 MIAMI FL 33131 786-396-6723
Telomir Pharmaceuticals, Inc. (Filer) CIK: 0001971532 (see all company filings)

IRS No.: 872606031 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41952 | Film No.: 241484549
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)